Lung ultrasound score to predict development of acute chest syndrome in children with sickle cell disease.

Pedro P M G Vieira, Josefina A P Braga, Rodrigo Regacini
{"title":"Lung ultrasound score to predict development of acute chest syndrome in children with sickle cell disease.","authors":"Pedro P M G Vieira, Josefina A P Braga, Rodrigo Regacini","doi":"10.1016/j.htct.2024.07.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to identify lung ultrasound (LUS) findings associated with acute chest syndrome (ACS) at the time of admission and 24-48 h later, to compare these to chest radiography (CXR) findings and to establish a score to predict the development of this pulmonary complication in sickle cell disease (SCD) children METHODS: A prospective observational study of SCD children presenting signs or symptoms of ACS evaluated by LUS and CXR at admission and 24-48 h later. A score was conceived to predict the evolution of ACS during hospitalization based on ultrasonographic findings.</p><p><strong>Results: </strong>Seventy-eight children were evaluated; 61 (78.2 %) developed ACS. A score greater than one at admission showed sensitivity, specificity, accuracy, and positive predictive value (PPV) of 75.4 %, 88.2 %, 78.2 %, and 95.8 %, respectively to predict ACS, while only 32 (52.5 %) CXR showed alterations. The development of ACS during hospitalization was unlikely for a score of zero and very likely for a score greater than one at admission. Regarding follow-up exams, a score greater than one showed sensitivity, specificity, accuracy, and PPV of 98.4 %, 76.5 %, 93.6 %, and 92.8 %, respectively to predict the development of ACS. ACS development was very unlikely for a score of zero and very likely for a score greater than zero in the follow-up.</p><p><strong>Conclusion: </strong>LUS is an effective tool to assess risk for the development of ACS in SCD children with clinical suspicion.</p>","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, transfusion and cell therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.htct.2024.07.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aims to identify lung ultrasound (LUS) findings associated with acute chest syndrome (ACS) at the time of admission and 24-48 h later, to compare these to chest radiography (CXR) findings and to establish a score to predict the development of this pulmonary complication in sickle cell disease (SCD) children METHODS: A prospective observational study of SCD children presenting signs or symptoms of ACS evaluated by LUS and CXR at admission and 24-48 h later. A score was conceived to predict the evolution of ACS during hospitalization based on ultrasonographic findings.

Results: Seventy-eight children were evaluated; 61 (78.2 %) developed ACS. A score greater than one at admission showed sensitivity, specificity, accuracy, and positive predictive value (PPV) of 75.4 %, 88.2 %, 78.2 %, and 95.8 %, respectively to predict ACS, while only 32 (52.5 %) CXR showed alterations. The development of ACS during hospitalization was unlikely for a score of zero and very likely for a score greater than one at admission. Regarding follow-up exams, a score greater than one showed sensitivity, specificity, accuracy, and PPV of 98.4 %, 76.5 %, 93.6 %, and 92.8 %, respectively to predict the development of ACS. ACS development was very unlikely for a score of zero and very likely for a score greater than zero in the follow-up.

Conclusion: LUS is an effective tool to assess risk for the development of ACS in SCD children with clinical suspicion.

预测镰状细胞病患儿急性胸部综合征发展的肺部超声波评分。
研究目的本研究旨在确定入院时和 24-48 小时后与急性胸部综合征(ACS)相关的肺部超声波(LUS)检查结果,将这些结果与胸部X光检查(CXR)结果进行比较,并建立预测镰状细胞病(SCD)患儿肺部并发症发展的评分方法:一项前瞻性观察研究,研究对象为入院时和 24-48 小时后出现 ACS 体征或症状的 SCD 患儿,通过 LUS 和 CXR 进行评估。根据超声波检查结果设计了一个评分标准,用于预测住院期间 ACS 的演变情况:结果:78 名儿童接受了评估,其中 61 名(78.2%)患上了 ACS。入院时评分大于 1 分的患儿预测 ACS 的敏感性、特异性、准确性和阳性预测值(PPV)分别为 75.4%、88.2%、78.2% 和 95.8%,而只有 32 名患儿(52.5%)的 CXR 出现了变化。如果入院时的评分为零,则在住院期间发生 ACS 的可能性不大;如果评分大于 1,则发生 ACS 的可能性很大。在随访检查中,得分大于 1 的患者预测发生 ACS 的敏感性、特异性、准确性和 PPV 分别为 98.4%、76.5%、93.6% 和 92.8%。在随访中,得分为零的患者发生 ACS 的可能性很小,得分大于零的患者发生 ACS 的可能性很大:结论:LUS 是评估临床可疑 SCD 儿童发生 ACS 风险的有效工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信